Smart diet plan uses glucose monitors to help asian americans tame diabetes

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Eligible participants (N=120; 60 Chinese Americans and 60 Vietnamese Americans) * Community-dwelling adults aged ≥ 18 with independent living; * Diagnosed with T2D; * Hb1Ac\>7.0% * Self-identified as first- or second-generation Chinese or Vietnamese immigrants; * Able to communicate in English, Chinese, or Vietnamese. We will focus on Mandarin-, Cantonese- or English-speaking Chinese Americans because the two best-known and most-spoken variants of Chinese are Mandarin and Cantonese, who use the same writing system; * Have a smartphone, iPad, tablet, or Apple watch Exclusion Criteria: * Taking hypoglycemia agents (e.g., insulin and sulfonylureas) with the major side effect of hypoglycemia that need close monitoring the occurrence of hypoglycemia to adjust/reduce medications to avoid future hypoglycemia. * Taking medications that impede weight loss (e.g., prednisone) within the last 3 months. * Currently pregnant, breastfeeding, or contemplating pregnancy within the next 6 months. * Have serious physical complications (e.g., severe neuropathy cardiovascular disease, COPD/emphysema, osteoarthritis, or stroke) or mental disease (e.g., schizophrenia, bipolar disorder, manic depressive illness, severe depression, or active substance abuse). * Have conditions that restrict diet, such as severe gastroparesis, ulcers, or food allergies. These conditions may need special dietary intervention. * Undergoing treatment for cancer, as cancer treatment may impact the outcome of glucose changes. * Have marked renal impairment (eGRF\<45; CKD-3b), as renal impairment may needs special dietary intervention and they also may impact glucose changes. * Are taking psychotropic medications that raise blood glucose (e.g., atypical antipsychotics). * Are prior or current CGM users including both Dexcom and FreeStyle Libre and plan to continuously use these CGMs in the next 6 months. * Are participating in another T2D intervention study.